MALT1 gene rearrangements and NF-κB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast

Autor: Carlos E. Bueso-Ramos, Jose R. Valbuena, Sameer S. Talwalkar, L. Jeffrey Medeiros, Lynne V. Abruzzo, Sergej Konoplev, Joan H. Admirand
Rok vydání: 2006
Předmět:
Adult
Male
Pathology
medicine.medical_specialty
Breast Neoplasms
Biology
Breast Neoplasms
Male

Pathology and Forensic Medicine
immune system diseases
hemic and lymphatic diseases
medicine
Humans
In Situ Hybridization
Fluorescence

Adaptor Proteins
Signal Transducing

Aged
Aged
80 and over

Gene Rearrangement
medicine.diagnostic_test
NF-kappa B
Transcription Factor RelA
NF-kappa B p50 Subunit
MALT lymphoma
Lymphoma
B-Cell
Marginal Zone

Gene rearrangement
Middle Aged
B-Cell CLL-Lymphoma 10 Protein
medicine.disease
Immunohistochemistry
Neoplasm Proteins
Lymphoma
Staining
Gene Expression Regulation
Neoplastic

Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein
Caspases
Female
Lymphoma
Large B-Cell
Diffuse

Mucosa-associated lymphoid tissue
Immunostaining
Fluorescence in situ hybridization
Zdroj: Modern Pathology. 19:1402-1408
ISSN: 0893-3952
DOI: 10.1038/modpathol.3800668
Popis: Mucosa associated lymphoid tissue (MALT) lymphomas arising in the breast are uncommon and few cases have been assessed for MALT lymphoma-associated translocations, BCL-10 expression, or NF-kappaB activation. In this study, we analyzed eight cases of primary breast MALT lymphoma. We also included 14 cases of primary breast diffuse large B-cell lymphoma since some of these may represent transformation of MALT lymphoma, known to occur at extra-mammary MALT sites. All cases were assessed for MALT1 gene rearrangements by fluorescence in situ hybridization (FISH). Using immunohistochemical methods, all cases were assessed for BCL-10, and subsets were assessed for NF-kappaB p65 and p50. None of the cases had MALT1 gene rearrangements by FISH. Of eight MALT lymphomas, BCL-10 was positive in seven (88%), with moderate nuclear and cytoplasmic staining in six, and a weak cytoplasmic staining in one. NF-kappaB p65 (n=8) and p50 (n=5) were negative or showed only cytoplasmic staining (ie inactivated) in all cases. Of 14 diffuse large B-cell lymphoma cases, BCL-10 was positive in 12 (87%), with weak-to-moderate cytoplasmic staining in 10, weak cytoplasmic and focally nuclear staining in one, and a moderate-to-strong nuclear and cytoplasmic staining in one. NF-kappaB p65 (n=11) showed cytoplasmic staining in all cases, whereas p50 (n=8) showed nuclear positivity (ie activated) in two (25%) cases. We conclude that MALT1 gene rearrangements are absent or rare in primary breast MALT lymphoma and diffuse large B-cell lymphoma. In MALT lymphomas, the moderate BCL-10 nuclear expression in six neoplasms is inconsistent with the FISH results, suggesting that BCL-10 immunostaining overestimates the frequency of MALT1 gene rearrangements. We also could not demonstrate NF-kappaB activation using nuclear staining for p65 and p50. In contrast, breast diffuse large B-cell lymphomas are heterogeneous. Weak cytoplasmic BCL-10 staining in most cases and evidence of NF-kappaB p50 activation in a subset differs from breast MALT lymphomas.
Databáze: OpenAIRE